-
THE USE OF POPULATION LEVEL REGISTRY DATA TO INFORM CURE ASSUMPTIONS AND SURVIVAL EXTRAPOLATIONS: A CASE STUDY IN NON-MUSCLE INVASIVE BLADDER CANCER
Aug 11, 2026, 17:15 PM -
APPLICATIONS FOR ROMOSOZUMAB (EVENITY) UNDER A MANAGED ACCESS PROTOCOL IN IRELAND
Aug 11, 2026, 17:15 PM -
REAL-WORLD FARICIMAB DOSING INTERVALS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: ASSOCIATED REDUCTIONS IN HEALTHCARE RESOURCE USE, COSTS, AND TRAVEL-RELATED CARBON EMISSIONS
Aug 11, 2026, 17:15 PM -
CONTEMPORARY REAL-WORLD PATIENT CHARACTERISTICS, TREATMENT PATTERNS, AND CLINICAL OUTCOMES IN METASTATIC UVEAL MELANOMA IN THE UNITED STATES
Aug 11, 2026, 17:15 PM -
COST ANALYSIS OF CONTINUOUS GLUCOSE MONITORING (CGM) POLICY CHANGES IN CAMPANIA, ITALY
Aug 11, 2026, 17:15 PM -
DIFFERENT HORIZONS, UNEVEN GAINS: TEMPORAL TRENDS IN ADMISSION-ANCHORED OUTCOMES FROM FIRST HFREF HOSPITALIZATION IN SINGAPORE
Aug 11, 2026, 17:15 PM -
CLOUD-BASED LARGE LANGUAGE MODELS TO SCREEN ABSTRACTS FOR TARGETED LITERATURE REVIEWS - TIME SAVED AND ACCURACY IMPROVEMENT
Aug 11, 2026, 17:15 PM -
CHARACTERIZING THE MULTI-DIMENSIONAL BURDEN OF DISEASE AND GAPS IN SUPPORT AMONG PEOPLE WITH OBESITY UTILISING GLP-1 RECEPTOR AGONISTS
Aug 11, 2026, 17:15 PM -
MODELING THE DETERMINANTS OF INDIVIDUAL MEDICAL EXPENDITURES AN ECONOMETRIC AND MACHINE LEARNING ANALYSIS OF THE ROLE OF AGE OBESITY AND SMOKING
Aug 11, 2026, 17:15 PM -
CLINICAL AND ECONOMIC IMPACT OF 20% WEIGHT REDUCTION IN MILITARY HEALTHCARE INSTITUTIONS IN THE KINGDOM OF SAUDI ARABIA USING THE VALUE OF WEIGHT LOSS SIMULATION MODEL
Aug 11, 2026, 17:15 PM -
COST-CONSEQUENCE ANALYSIS OF COVERED BALLOON-EXPANDABLE STENTS USING EXTRAPOLATED 3-YEAR OUTCOMES FOR AORTOILIAC OCCLUSIVE DISEASE IN THE UK
Aug 11, 2026, 17:15 PM -
CANCER BURDEN ATTRIBUTABLE TO MODIFIABLE RISK FACTORS IN HUNGARY: INCORPORATING THE HUN-CANCER EPIDEMIOLOGICAL DATABASE INTO GLOBAL FRAMEWORKS
Aug 11, 2026, 17:15 PM -
ECONOMIC IMPACT OF ORAL CORTICOSTEROID-RELATED COMORBIDITIES IN PATIENTS WITH ACETYLCHOLINE RECEPTOR ANTIBODY-POSITIVE (ACHR-AB+) GENERALISED MYASTHENIA GRAVIS (GMG) IN THE UNITED STATES (US)
Aug 11, 2026, 17:15 PM -
DISTRIBUTION OF INCREMENTAL QALY ESTIMATES REPORTED IN HTA CONCLUSIONS IN UKRAINE (2022-2026)
Aug 11, 2026, 17:15 PM -
MLUMR: AN R PACKAGE FOR POPULATION-ADJUSTED INDIRECT COMPARISONS USING MULTILEVEL UNANCHORED META-REGRESSION
Aug 11, 2026, 17:15 PM -
DETERMINANTS OF INDIVIDUAL AND FAMILY PRIVATE HEALTH INSURANCE OWNERSHIP IN GREECE: EVIDENCE FROM A NATIONAL SURVEY
Aug 11, 2026, 17:15 PM -
COST-EFFECTIVENESS OF BREAST CANCER TREATMENT ACROSS DISEASE STAGES: EVIDENCE FROM A REAL-WORLD COHORT
Aug 11, 2026, 17:15 PM -
THE EUROPEAN PROXY TARIFF PROBLEM: WHICH EQ-5D-5L VALUE SET BEST SERVES COUNTRIES WITHOUT NATIONAL TARIFFS?
Aug 11, 2026, 17:15 PM -
UNLOCKING THE VALUE OF BIOLOGIC THERAPIES IN MULTIPLE MYELOMA: THE POTENTIAL OF ON-BODY INJECTORS TO IMPROVE HEALTHCARE EFFICIENCY AND SERVICE DELIVERY
Aug 11, 2026, 17:15 PM -
BUDGET IMPACT OF POST-STROKE SPASTICITY MANAGEMENT USING ABOBOTULINUMTOXINA: HOSPITAL-AT-HOME VERSUS TRADITIONAL HOSPITAL CARE - A FRENCH PERSPECTIVE
Aug 11, 2026, 17:15 PM
